OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Company News Release
January 20th, 2009-PII, (Pharmaceutics International, Inc.) announced today the formal launch of a new business initiative, PII Drug Delivery Solutions. In response to demand from its clients for product development tools that meet the challenges of problematic new chemical entities (NCEs) and of product life cycle management (LCM), PII has put together a strategy and dedicated resources focused on drug delivery. This new initiative, named PII Drug Delivery Solutions builds on the PII’s proven track record in formulation development and pharmaceutical manufacturing to help its clients bring new products to market with optimized clinical profiles and higher commercial value.
Since its inception, PII has built considerable expertise in drug delivery, including conventional controlled release formulation approaches, a portfolio of PII – developed technologies and programs involving third-party platforms-its alliance with Penwest Pharmaceuticals for TIMERx technology being an example.
The strategy for PII Drug Delivery Solutions is to provide dedicated business development, centers of technical excellence, proactive partnering and integrated support from PII core resources. PII believes that its exciting portfolio of in-house and partnered drug delivery technologies can be put to work to assist clients with their product development needs, be they early-stage drug candidate optimization through to the revitalization of a marketed compound.
Steve King, Senior Vice President of PII said, “Our dedicated business development team lead by Robin Mitchell and Susan Wiggins has extensive experience in drug delivery and contract services. We aim to proactively bring creative problem solving solutions and product concepts to our clients. PII already has a very powerful portfolio of technology platforms at our disposal and intends to build on this during 2009.” “PII has quietly developed some impressive technologies of its own-nanoparticle formulations and MedCrystalForms’ mixed phase co-crystals for enhanced drug bioavailability for example. Through our partnerships with companies like Penwest, we can tackle a broad range of controlled release challenges too”, said Robin Mitchell, Senior Director Drug Delivery Solutions adding, “Susan Wiggins and I are very excited about the role that we can play to strengthen our clients’ business success in today’s very competitive markets."
A new website launched today-www.piidds.com-introduces PII Drug Delivery Solutions. The site will feature PII’s growing portfolio of capabilities and resources as it expands.
About Pharmaceutics International, Inc.
PII is a privately held leading multi-national Drug Delivery Solutions company providing services to facilitate drug development with or without patented technologies. The corporate headquarters are located in Hunt Valley Maryland USA with a European facility in Reading, UK. Services range from preformulation, formulation development, manufacture of clinical trial material through to commercial
manufacture. For further information about PII go to: www.piidds.com and www.pharm-int.com